Clinical Trial Update: Study to Evaluate Imatinib in Desmoid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating imatinib in desmoid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid Tumor
• Desmoid-type Fibromatosis

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Heidelberg University | Conditions: Aggressive Fibromatosis, Desmoid Tumor | Phase 2 | Status: COMPLETED